USPTO serial 85621672
LEO PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 26, 2013
- Examiner
- REGAN, JOHN B
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with LEO PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Brett Heavner
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner, LL901 New York Avenue NWWASHINGTON, DC 20001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Providing educational and training services, namely, [ conducting classes, ] seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; educational training services in the field of treatment of cancer and dermatological, hematological, renal and endocrine disorders; education services, namely, providing on-line [ classes, ] seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; [ arranging and conducting of lectures in the field of cancer and dermatological, hematological, renal and endocrine disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; ]providing on-line electronic publications, namely, books, booklets, brochures, papers, periodical publications, [ magazines,] newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; publication of [ books, booklets, ] brochures, papers, periodical publications, [ magazines, newspapers ] and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing online educational and informational games in the field of cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and dermatological, hematological, renal and endocrine disorders; conducting clinical trials for pharmaceutical products in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing information about the results of clinical trials for pharmaceutical products [; providing online non-downloadable software applications containing information on the use of pharmaceutical products and for calculating use of medicine ] | ACTIVE | — |
| 044 | Providing medical information, consultancy and advisory services; medical and pharmaceutical consultation; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; [ medical counseling; medical services, namely, medical care in the field of cancer and dermatological, hematological, renal and endocrine disorders; ] planning of medical treatment programs for the treatment of cancer and dermatological, hematological, renal and endocrine disorders; providing information and advice in the fields of cancer and dermatological, hematological, renal and endocrine disorders; providing a web site featuring medical information; [ hygienic and beauty care; ] information services in the field of treatment of cancer and dermatological, haematological [, renal and endocrine disorders ] | ACTIVE | — |
| 045 | [ Personal and social services rendered by others to meet the needs of individuals, namely, providing non-therapeutic counseling and emotional support to patients and families of patients, and providing information to relatives on how to provide emotional support to patients and families of patients ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Leo Pharma A/S
- Other trademarks owned by Leo Pharma A/S
- Other trademarks owned by Leo Pharma A/S
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named LEO PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 16, 2023 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Sep 16, 2023 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Sep 16, 2023 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Sep 16, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 8, 2023 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 26, 2022 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 31, 2019 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 31, 2019 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 31, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 19, 2019 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 26, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 5, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 8, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 8, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 1, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 1, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 16, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 13, 2012 | ALIE | ASSIGNED TO LIE | — |
| Nov 5, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2012 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 5, 2012 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 5, 2012 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 29, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 14, 2012 | NWAP | NEW APPLICATION ENTERED | — |